Cargando…
Radiation recall dermatitis during treatment of endometrial cancer with pembrolizumab plus lenvatinib: A case report
Radiation Recall encompasses an array of inflammatory reactions, most commonly dermatitis, that occurs in response to a systemic medication with distribution in a previously irradiated field. While historically cytotoxic chemotherapy was a major culprit, this case report describes radiation recall d...
Autores principales: | Heisler, Elise, Tunnage, Irina, Growdon, Whitfield |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391910/ https://www.ncbi.nlm.nih.gov/pubmed/37533427 http://dx.doi.org/10.1016/j.gore.2023.101239 |
Ejemplares similares
-
Esophagitis as a complication of the combination of lenvatinib and pembrolizumab for advanced endometrial cancer: A case report
por: Fellouah, Massine, et al.
Publicado: (2023) -
Pembrolizumab and lenvatinib in recurrent ovarian clear cell carcinoma resistant to chemotherapy
por: McNamara, Blair, et al.
Publicado: (2023) -
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
por: Makker, Vicky, et al.
Publicado: (2020) -
Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity
por: Staropoli, Nicoletta, et al.
Publicado: (2023) -
Radiation Recall Dermatitis Following Treatment With Pembrolizumab: A Case
Report and Review of the Literature
por: Sandhu, Michael, et al.
Publicado: (2023)